GP29 The effect of 2015 revised jones criteria on acute rheumatic fever diagnosis

Abstract

Background and objectives Atrial septal defect (ASD) is a deficiency in the atrial septum leading to an abnormal communication between the right and left atria. Defects of the atrial septum are the third most common type of congenital heart disease comprising 6% of all lesions. Transcatheter closure of secundum type ASD is an alternative to surgical closure in many cases when conditions are appropriate. Studies have shown that closure of secundum type atrial septal defects with devices is a safe and successful method. In this study, we planned to share the demographic datas and postoperative follow-up results of patients with secundum atrial septal defect undergoing transcatheter closure. Methods Data of patients underwent transcatheter closure of secundum type atrial septal defect between 2004 to 2017 was investigated retrospectively. Gender, age at intervention, defect size (with transthoracic, transesophageal echocardiography), procedure duration, fluoroscopy time, periprocedural complications, residual shunt existence and long term follow-up results were collected. Results In 179 patients (41% males;%10 adults, median age, 8,1 years [1,3 to 58,6]; weight, 28 kg [11 to 90]), admitted to catheterization for ASD closure. Median ASD size was 13 mm (6 to 30); 74 (41%) patients had a large ASD (!12 mm). Suitable defects for closure were 165 of 179 patients. Three types of devices were used during procedure most used being Amplatzer Septal Occluder. Procedural success rate was 95,7%. No death was observed but periprocedural complications occurred in 3 patients (1,6%). Periprocedural complications were AV(atrioventricular) block, atrial flutter and brachial plexus paralysis. After a median follow-up of 2,8 years (range 6 months to 13,6 years; 16 patients [10%] followed >10 years), delayed major complications such as death, cardiac erosion, infective endocarditis were not experienced. Delayed minor complications were supraventricular extrasystole not required treatment and mild mitral regurgitation worsening in 2 patients (1,3%). The rate of residual shunt was 1,3% at one year follow-up and all shunts were mild. Conclusions Transcatheter ASD closure is safe in children with a minimal rate of periprocedural complications and a favorable long-term outcome, especially with no death or major complications. Residual shunt ratio is also low and insignificant. Transcatheter ASD closure can be done safely in experienced centers as an alternative treatment to surgery.Background The urgency of the problem is determined by the high infant mortality and disability associated with critical CHD (CCHD) and persistent pulmonary hypertension in newborns (PPHN). The difficulty of diagnosing critical CHD and persistent pulmonary hypertension in newborns leads to a delayed accurate diagnosis, which is the cause of late hospitalization in specialized hospitals in a difficult and often critical condition. This research paper presents a method for the early detection of newborns with PPHN and critical CHD using pulse oximetry, which differs...